Previous studies have shown that vimentin was upregulated in several types of cancer with poor prognoses, which is highly correlated with the upregulation of the EMT-related transcription factor, slug, and the downregulation of the adherent protein, E-cadherin [34, 35]. This evidence concerns the gene VIM and cancer.